KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Recursion Pharmaceuticals (RXRX) Change in Intangibles (2022 - 2024)

Historic Change in Intangibles for Recursion Pharmaceuticals (RXRX) over the last 3 years, with Q4 2024 value amounting to $350000.0.

  • Recursion Pharmaceuticals' Change in Intangibles changed 0.0% to $350000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.4 million for FY2024, which is 46113.9% up from last year.
  • Latest data reveals that Recursion Pharmaceuticals reported Change in Intangibles of $350000.0 as of Q4 2024, which was down 0.0% from $3.0 million recorded in Q2 2024.
  • Recursion Pharmaceuticals' Change in Intangibles' 5-year high stood at $3.0 million during Q2 2024, with a 5-year trough of $82000.0 in Q3 2023.
  • For the 3-year period, Recursion Pharmaceuticals' Change in Intangibles averaged around $707833.3, with its median value being $325000.0 (2022).
  • In the last 5 years, Recursion Pharmaceuticals' Change in Intangibles tumbled by 7266.67% in 2023 and then changed by 0.0% in 2024.
  • Over the past 3 years, Recursion Pharmaceuticals' Change in Intangibles (Quarter) stood at $300000.0 in 2022, then grew by 16.67% to $350000.0 in 2023, then changed by 0.0% to $350000.0 in 2024.
  • Its last three reported values are $350000.0 in Q4 2024, $3.0 million for Q2 2024, and $350000.0 during Q4 2023.